Pulmonary Fibrosis News and Research

RSS
CPF announces nationwide advertising campaign to increase awareness about PF

CPF announces nationwide advertising campaign to increase awareness about PF

Geron second-quarter net loss decreases to $17.0 million

Geron second-quarter net loss decreases to $17.0 million

Celgene second-quarter non-GAAP total revenue increases 36% to $850 million

Celgene second-quarter non-GAAP total revenue increases 36% to $850 million

InterMune second-quarter total revenue decreases to $5.9 million

InterMune second-quarter total revenue decreases to $5.9 million

Activities of TAT fully consolidated into Geron

Activities of TAT fully consolidated into Geron

FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations

FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations

NBC's TODAY Show to focus on PF in an interview with a patient from California

NBC's TODAY Show to focus on PF in an interview with a patient from California

NeoPharm first-quarter net loss decreases to $1.4 million

NeoPharm first-quarter net loss decreases to $1.4 million

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Highlights from June 2010 issue of American Journal of Pathology

Highlights from June 2010 issue of American Journal of Pathology

2010 funding program for Inova Life Sciences - George Mason University research collaboration open

2010 funding program for Inova Life Sciences - George Mason University research collaboration open

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

NAC therapy shows promise for patients with mild IPF

NAC therapy shows promise for patients with mild IPF

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

FDA grants NeoPharm's IL13-PE38QQR orphan-drug designation for treatment of IPF

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

Celgene's first-quarter non-GAAP total revenue up 31% to $789 million

Celgene's first-quarter non-GAAP total revenue up 31% to $789 million

Small piece of RNA plays big role in development of IPF: Researchers

Small piece of RNA plays big role in development of IPF: Researchers

Three nonprofit organizations launch campaign to increase national awareness of PF

Three nonprofit organizations launch campaign to increase national awareness of PF

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.